Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis

Transplant Proc. 1998 Nov;30(7):3072-3. doi: 10.1016/s0041-1345(98)00935-x.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Angiotensin Receptor Antagonists*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Female
  • Hematocrit*
  • Humans
  • Kidney Transplantation*
  • Losartan / adverse effects
  • Losartan / therapeutic use*
  • Male
  • Polycythemia / blood
  • Polycythemia / drug therapy*
  • Polycythemia / etiology
  • Postoperative Complications
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Losartan